Skip to main content

Table 1 Patient Demographics

From: The clinical relevance of luteal phase progesterone support in true natural cycle cryopreserved blastocyst stage embryo transfers: a retrospective cohort study

 

Progesterone (n = 149 [65%])

No Progesterone (n = 80 [35%])

Age of women producing oocytes (years)

34.2 (3.9)

35.6 (3.1)

BMI at egg retrieval (kg/m2)

24.6 (6.1)

25.1 (6.8)

Gravity

1.4 (1.6)

1.2 (1.5)

Parous Y/N

48 (32.2%)

32 (40.0%)

Infertility Diagnosis

n (%)

 

DOR

26 (17.5%)

6 (7.5%)

 Unexplained

59 (39.6%)

33 (41.3%)

 Uterine factor

8 (5.4%)

4 (5.0%)

 Anovulatory

10 (6.7%)

3 (3.8%)

 Endometriosis

9 (6.0%)

6 (7.5%)

 Tubal Factor

17 (11.4%)

6 (7.5%)

 Male Factor

32 (21.5%)

24 (30.0%)

AMH at start of retrieval cycle

3.4 (3.1) (n = 131)

4.1 (3.7) (n = 73)

Race/ethnicity of recipient

n (%)

 

Caucasian or White

115 (77.2%)

55 (68.8%)

Black or African American

6 (4.0%)

3 (3.8%)

Hispanic or Latino/a

0

1 (1.3%)

American Indian or Alaska Native

1 (0.7%)

0

Asian

23 (15.4%)

19 (23.8%)

Other/Unknown

4 (2.7%)

2 (3.0%)

Average number of prior transfers at BWH

3.2 (3.0)

3.0 (3.4)

No prior transfers at BWH

14 (9.4%)

5 (6.3%)

  1. Values are mean (SD)
  2. AMH Antimullerian hormone, BWH Brigham and Women’s Hospital
  3. Infertility diagnoses add up to more than 100% as some patients have multiple diagnoses and each was included in the analysis